Notification of Interim Results

RNS Number : 0613R
Immupharma PLC
19 September 2017
 

 

FOR IMMEDIATE RELEASE                                                                            19 SEPTEMBER 2017

 

 

 

ImmuPharma PLC

("ImmuPharma" or the "Company")

 

NOTIFICATION OF INTERIM RESULTS

Date: 27 September 2017

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, confirms that it will be announcing its Interim results for the six months ended 30 June 2017 on Wednesday 27 September 2017.

 

 

-Ends-

 

 

 

For further information please contact:

 

ImmuPharma plc (www.immupharma.org)

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman

 

Lisa Baderoon, Head of Investor Relations

Twitter: @immupharma

 

+ 44 (0) 7721 413496

 

 

 

 

 

Northland Capital Partners Limited (Joint Broker)

Patrick Claridge, David Hignell, Jamie Spotswood, Corporate Finance

Rob Rees, Corporate Broking

 

 

                                                  

+44 (0)20 3861 6625

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORXVLFFDKFLBBQ

Companies

Immupharma (IMM)
UK 100

Latest directors dealings